Edwards Lifesciences Corporation
EW
Rang în acțiuni
#476
Edwards Lifesciences Corporation is a global medical technology firm... Edwards Lifesciences Corporation is a global medical technology firm specializing in sophisticated products and technologies for structural heart conditions, alongside critical care and surgical patient monitoring. With operations spanning the United States, Europe, Japan, and various international territories, the company offers a comprehensive suite of solutions. Their structural heart disease portfolio encompasses transcatheter heart valve replacement systems designed for minimally invasive procedures, as well as transcatheter repair and replacement options specifically targeting mitral and tricuspid valve pathologies, exemplified by their PASCAL and Cardioband systems. Additionally, they provide advanced surgical structural heart solutions, including the INSPIRIS aortic surgical valve, the KONECT RESILIA pre-assembled aortic tissue valved conduit for complex valve, root, and ascending aorta replacements, and the HARPOON Beating Heart Mitral Valve Repair System for patients suffering from degenerative mitral regurgitation. In the realm of critical care, Edwards supplies advanced hemodynamic monitoring systems that assess patients' cardiac function and fluid status in both surgical and intensive care environments. This offering also features the Acumen Hypotension Prediction Index software, which provides early alerts to clinicians regarding potential dangerously low blood pressure. The company distributes its products to healthcare providers through a combination of its proprietary sales force and independent distributor networks. Founded in 1958, Edwards Lifesciences Corporation maintains its headquarters in Irvine, California.
Preț acțiune
$88.24
Capitalizare de piață
$50.86B
Schimbare (1 zi)
1.08%
Schimbare (1 an)
17.19%
Țară
US
Tranzacționează Edwards Lifesciences Corporation (EW)
Categorie
Healthcare
Venituri pentru Edwards Lifesciences Corporation (EW)
Venituri în Jun 2026 TTM: $6.51B
Conform celor mai recente rapoarte financiare ale Edwards Lifesciences Corporation, venitul actual al companiei (TTM) este $6.51B. În anul 2024, compania a avut un venit de $5.44B o creștere față de venitul din anul 2023, care a fost de $5.01B. Venitul reprezintă suma totală generată de o companie din vânzarea de bunuri sau servicii. Spre deosebire de profit, cheltuielile nu sunt scăzute.
Istoricul veniturilor pentru Edwards Lifesciences Corporation din 2000 până în 2026
Venituri la sfârșitul fiecărui an
| An | Venituri | Schimbă |
|---|---|---|
| 2026 (TTM) | $6.51B | 7.33% |
| 2025 | $6.07B | 11.55% |
| 2024 | $5.44B | 8.57% |
| 2023 | $5.01B | -6.92% |
| 2022 | $5.38B | 2.86% |
| 2021 | $5.23B | 19.29% |
| 2020 | $4.39B | 0.88% |
| 2019 | $4.35B | 16.79% |
| 2018 | $3.72B | 8.37% |
| 2017 | $3.44B | 15.91% |
| 2016 | $2.96B | 18.85% |
| 2015 | $2.49B | 7.35% |
| 2014 | $2.32B | 13.56% |
| 2013 | $2.05B | 7.68% |
| 2012 | $1.90B | 13.17% |
| 2011 | $1.68B | 16.01% |
| 2010 | $1.45B | 9.51% |
| 2009 | $1.32B | 6.76% |
| 2008 | $1.24B | 13.44% |
| 2007 | $1.09B | 5.22% |
| 2006 | $1.04B | 3.92% |
| 2005 | $997.90M | 7.13% |
| 2004 | $931.50M | 8.25% |
| 2003 | $860.50M | 22.23% |
| 2002 | $704.00M | 1.73% |
| 2001 | $692.00M | -13.93% |
| 2000 | $804.00M | 0.00% |
Venituri pentru companii similare sau concurente
| Companie | Venituri | Diferență de venituri | Țara |
|---|---|---|---|
| $46.59B | 615.34% |
US
|
|
| $35.48B | 444.88% |
IE
|
|
| $25.84B | 296.74% |
US
|
|
| $21.00B | 222.41% |
US
|
|
| - | - |
DE
|
